natgillin/translations-raw huggingface dataset:
Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (OL L 351, 30.12.2017, p. 72).
Provedbena uredba Komisije (EU) 2017/2470 оd 20. prosinca 2017. o utvrđivanju Unijina popisa nove hrane u skladu s Uredbom (EU) 2015/2283 Europskog parlamenta i Vijeća o novoj hrani (SL L 351, 30.12.2017., str. 72.).
Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel foods ingredients (OJ L 43, 14.2.1997, p. 1).
Uredba (EZ) br. 258/97 Europskog parlamenta i Vijeća od 27. siječnja 1997. o novoj hrani i sastojcima nove hrane (SL L 43, 14.2.1997., str. 1.).
EFSA Journal 2017;15(10):5003.
EFSA Journal 2017.; 15(10):5003.
Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Iodine, 7.10.2002.
Mišljenje Znanstvenog odbora za hranu o prihvatljivoj gornjoj granici unosa joda, 7. listopada 2002.
The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows
Prilog Provedbenoj uredbi (EU) 2017/2470 mijenja se kako slijedi:
The following entry is inserted in Table 1 (Authorised novel foods) in alphabetical order:
Sljedeći unos umeće se abecednim redom u tablicu 1. (Odobrena nova hrana):
Authorised novel food
Odobrena nova hrana
Conditions under which the novel food may be used
Uvjeti pod kojima se nova hrana može upotrebljavati
Additional specific labelling requirements
Dodatni posebni zahtjevi za označivanje proizvoda
‘Ecklonia cava phlorotannins
„Florotanini iz alge Ecklonia cava
Specified food category
Određena kategorija hrane
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Ecklonia cava Phlorotannins’.
Pri označivanju hrane koja sadržava novu hranu navodi se ‚Florotanini iz alge Ecklonia cava’.
Food supplements containing Ecklonia cava phlorotannins shall bear the following statement:
Na dodacima prehrani koji sadržavaju florotanine iz alge Ecklonia cava navodi se sljedeća izjava:
This food supplement should not be consumed by children/adolescents under the age of twelve/fourteen/eighteen (*) years.
Ovaj dodatak prehrani ne smiju konzumirati djeca i adolescenati mlađi od dvanaest/četrnaest/osamnaest (*) godina.
This food supplement should not be consumed by persons with thyroid disease or by persons who are aware of or have been identified as being at risk of developing thyroid disease.
Ovaj dodatak prehrani ne smiju konzumirati osobe oboljele od bolesti štitnjače ili osobe koje su svijesne da su izložene riziku razvoja bolesti štitnjače ili za koje je utvrđeno da su u rizičnoj skupini osoba koje bi mogle razviti bolest štitnjače.
This food supplement should not be consumed if other food supplements containing iodine are also consumed.
Ovaj dodatak prehrani ne smije se konzumirati ako se konzumiraju drugi dodaci prehrani koji sadržavaju jod.
Depending on the age group the food supplement is intended for.’
Ovisno o dobnoj skupini kojoj je dodatak prehrani namijenjen.”
Food Supplements as defined in Directive 2002/46/EC intended for the general population, excluding children under the age of 12 years
Dodaci prehrani u smislu Direktive 2002/46/EZ namijenjeni općoj populaciji, isključujući djecu mlađu od 12 godina
163 mg/day for adolescents from 12 to 14 years of age;
163 mg dnevno za adolescente u dobi od 12 do 14 godina;
230 mg/day for adolescents above 14 years of age;
230 mg dnevno za adolescente starije od 14;
263 mg/day for adults.
263 mg dnevno za odrasle.
The following entry is inserted in Table 2 (Specifications) in alphabetical order:
Sljedeći unos umeće se abecednim redom u tablicu 2. (Specifikacije):
Authorised Novel Food
Odobrena nova hrana
Ecklonia cava phlorotannins are obtained via alcohol extraction from the edible marine alga Ecklonia cava.
Florotanini iz alge Ecklonia cava dobivaju se alkoholnom ekstrakcijom iz jestive morske alge Ecklonia cava.
The extract is a dark brown powder, rich in phlorotannins, polyphenolic compounds found as secondary metabolites in certain brown algae species.
Ekstrakt je prah tamnosmeđe boje bogat florotaninima, odnosno polifenolnim spojevima koji su sekundarni metaboliti nekih vrsta smeđih algi.
Characteristics/Composition
Svojstva/sastav
Phlorotannin content: 90 ± 5 %
Sadržaj florotanina: 90 ± 5 %
Antioxidant activity: > 85 %
Antioksidacijska aktivnost: > 85 %
Moisture: < 5 %
Vlaga: < 5 %
Ash: < 5 %
Pepeo: < 5 %
Total viable cell count: < 3000 CFU/g
Ukupan broj živih stanica: < 3000 CFU/g
Mould/yeast: < 300 CFU/g
Plijesan/kvasac: < 300 CFU/g
Coliforms: Negative to test
Koliformi: Negativan test
Salmonella spp.: Negative to test
Salmonella spp.: Negativan test
Staphylococcus aureus: Negative to test
Staphylococcus aureus: Negativan test
Heavy metals and Halogens:
Teški metali i halogeni:
Lead: < 3,0 mg/kg
Olovo: < 3,0 mg/kg
Mercury: < 0,1 mg/kg
Živa: < 0,1 mg/kg
Cadmium: < 3,0 mg/kg
Kadmij: < 3,0 mg/kg
Arsenic: < 25,0 mg/kg
Arsen: < 25,0 mg/kg
Inorganic Arsenic: < 0,5 mg/kg
Anorganski arsen: < 0,5 mg/kg
Iodine: 150,0-650,0 mg/kg
Jod: 150,0 – 650,0 mg/kg
CFU: Colony Forming Units’
CFU: jedinice koje tvore kolonije.”
Commission Implementing Regulation (EU) 2018/461
Provedbena uredba Komisije (EU) 2018/461
authorising an extension of use of taxifolin-rich extract as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) 2017/2470
o odobravanju proširenja uporabe ekstrakta bogatog taksifolinom kao nove hrane u skladu s Uredbom (EU) 2015/2283 Europskog parlamenta i Vijeća i o izmjeni Provedbene uredbe Komisije (EU) 2017/2470
Regulation (EU) 2015/2283 provides that only novel foods authorised and included in the Union list may be placed on the market within the Union.
Uredbom (EU) 2015/2283 predviđeno je da se samo nova hrana odobrena i uvrštena u popis Unije može stavljati na tržište u Uniji.
On 23 August 2010, the company Ametis JSC made a request to the competent authority of the United Kingdom to place taxifolin-rich extract from the wood of Dahurian larch (Larix gmelinii (Rupr.) Rupr) on the Union market as a novel food ingredient within the meaning of point (e) of Article 1(2) of Regulation (EC) No 258/97 of the European Parliament and of the Council.
Društvo Ametis JSC podnijelo je 23. kolovoza 2010. nadležnim tijelima Ujedinjene Kraljevine zahtjev za stavljanje na tržište Unije ekstrakta bogatog taksifolinom dobivenog iz drva dahurskog ariša (Larix gmelinii (Rupr.) Rupr) kao novog sastojka hrane u smislu članka 1. stavka 2. točke (e) Uredbe (EZ) br. 258/97 Europskog parlamenta i Vijeća.
The application requested for taxifolin-rich extract to be used in food supplements for a population older than fourteen years, and in non-alcoholic beverages, yogurt and chocolate confectionery for the general population excluding infants, young children and children up to 9 years.
Zahtjevom se zatražilo odobrenje uporabe ekstrakta bogatog taksifolinom u dodacima prehrani namijenjenima populaciji starijoj od 14 godina te u bezalkoholnim pićima, jogurtu i čokoladnim slasticama namijenjenima općoj populaciji, isključujući dojenčad, malu djecu i djecu mlađu od 9 godina.
On 13 December 2016, EFSA adopted a ‘Scientific Opinion on the safety of taxifolin-rich extract as a novel food pursuant to Regulation (EC) No 258/97’.
EFSA je 13. prosinca 2016. donijela „Znanstveno mišljenje o sigurnosti ekstrakta bogatog taksifolinom kao nove hrane u skladu s Uredbom (EZ) br. 258/97”.
In its opinion it concluded that taxifolin-rich extract is safe for the proposed uses and use levels.
U svojem je mišljenju zaključila da je ekstrakt bogat taksifolinom siguran u okviru predloženih uporaba i razina uporabe.
Commission Implementing Decision (EU) 2017/2079 authorised, in accordance with Regulation (EC) No 258/97, the placing on the market of taxifolin-rich extract from the wood of Dahurian larch (Larix gmelinii (Rupr.) Rupr) as a novel food to be used in food supplements intended for the general population, excluding infants, young children, children and adolescents younger than 14 years.
Provedbenom odlukom Komisije (EU) 2017/2079 odobreno je, u skladu s Uredbom (EZ) br. 258/97, stavljanje na tržište ekstrakta bogatog taksifolinom dobivenog iz drva dahurskog ariša (Larix gmelinii (Rupr.) Rupr) kao nove hrane za uporabu u dodacima prehrani namijenjenima općoj populaciji, isključujući dojenčad, malu djecu, djecu i adolescente mlađe od 14 godina.
This Implementing Regulation addresses the remainder of the uses and use levels for which authorisation was sought by the applicant.
Ovom Provedbenom uredbom obuhvaćaju se preostale uporabe i razine uporabe za koje je podnositelj zahtjeva zatražio odobrenje.
The Commission initiated a further evaluation before taking a final decision on the full scope of the application, in order to ensure, that taxifolin-rich extract is also safe when consumed in other forms than in food supplements by infants, young children and children younger than 9 years of age.
Komisija je prije donošenja konačne odluke o sveobuhvatnom području uporabe pokrenula dodatnu procjenu kako bi utvrdila je li za dojenčad, malu djecu i djecu mlađu od 9 godina konzumiranje ekstrakta bogatog taksifolinom, osim u dodacima prehrani, sigurno i u drugim oblicima.
On 3 May 2017, the applicant was informed of and agreed with the Commission's additional request to EFSA.
Podnositelj je 3. svibnja 2017. obaviješten o dodatnom zahtjevu koji je Komisija uputila EFSA-i i s njime se složio.
On 28 June 2017, the Commission consulted EFSA asking it to carry out a supplementary safety assessment for taxifolin-rich extract in non-alcoholic beverages, chocolate confectionery and milk products for all groups of population.
Komisija je 28. lipnja 2017. zatražila od EFSA-e da provede dodatnu procjenu sigurnosti za ekstrakt bogat taksifolinom u bezalkoholnim pićima, čokoladnim slasticama i mliječnim proizvodima namijenjenima svim skupinama stanovništva.
Pursuant to Article 35(1) of Regulation (EU) 2015/2283, any request for placing a novel food on the market within the Union submitted to a Member State in accordance with Article 4 of Regulation (EC) No 258/97 and for which the final decision has not been taken before 1 January 2018, shall be treated as an application submitted under Regulation (EU) 2015/2283.
U skladu s člankom 35. stavkom 1. Uredbe (EU) 2015/2283 svi zahtjevi za stavljanje nove hrane na tržište u Uniji koji su podneseni državi članici u skladu s člankom 4. Uredbe (EZ) br. 258/97 i za koje nije donesena konačna odluka prije 1. siječnja 2018. tretiraju se kao zahtjevi u skladu s Uredbom (EU) 2015/2283.
On 25 October 2017, EFSA adopted ‘Scientific Opinion on the safety of taxifolin-rich extract’.
EFSA je 25. listopada 2017. donijela „Znanstveno mišljenje o sigurnosti ekstrakta bogatog taksifolinom”.
The opinion gives sufficient grounds to establish that taxifolin-rich extract when used as an ingredient in non-alcoholic beverages, milk products and chocolate confectionery taking into account all population groups, complies with Article 12(1) of Regulation (EU) 2015/2283.
U mišljenju se iznosi dovoljno informacija na temelju kojih se može utvrditi da je, uzimajući u obzir sve skupine stanovništva, uporaba ekstrakta bogatog taksifolinom kao sastojka u bezalkoholnim pićima, mliječnim proizvodima i čokoladnim slasticama u skladu s člankom 12. stavkom 1. Uredbe (EU) 2015/2283.
Regulation (EU) No 1308/2013 of the European Parliament and of the Council lays down requirements for milk and milk products which apply to taxifolin-rich extract when used as an ingredient in milk products.
Uredbom (EU) br. 1308/2013 Europskog parlamenta i Vijeća utvrđeni su zahtjevi za mlijeko i mliječne proizvode koji se primjenjuju na ekstrakt bogat taksifolinom ako se upotrebljava kao sastojak u mliječnim proizvodima.
Pursuant to its point 2 of Part III of Annex VII taxifolin-rich extract cannot be used in milk products to replace, in whole or in part, any milk constituent.
U skladu s dijelom III. točkom 2. Priloga VII. ekstrakt bogat taksifolinom ne može se upotrebljavati u mliječnim proizvodima kako bi se u cijelosti ili djelomično nadomjestio bilo koji sastojak mlijeka.
The use of taxifolin-rich extract as a novel food in milk products therefore has to be limited accordingly.
Stoga se uporaba ekstrakta bogatog taksifolinom kao nove hrane u mliječnim proizvodima mora na odgovarajući način ograničiti.
The entry in the Union list of authorised novel foods as provided for in Article 8 of Regulation (EU) 2015/2283 referring to the substance taxifolin-rich extract shall be amended as specified in the Annex to this Regulation.
Unos u Unijin popis odobrene nove hrane kako je predviđeno člankom 8. Uredbe (EU) 2015/2283 koji se odnosi na tvar „ekstrakt bogat taksifolinom” mijenja se kako je navedeno u Prilogu ovoj Uredbi.
Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (OJ L 351, 30.12.2017, p. 72).
Provedbena uredba Komisije (EU) 2017/2470 оd 20. prosinca 2017. o utvrđivanju Unijina popisa nove hrane u skladu s Uredbom (EU) 2015/2283 Europskog parlamenta i Vijeća o novoj hrani (SL L 351, 30.12.2017., str. 72.).
EFSA Journal 2017; 15(2):4682
EFSA Journal 2017.; 15(2):4682.
Commission Implementing Decision (EU) 2017/2079 of 10 November 2017 authorising the placing on the market of taxifolin-rich extract as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (OJ L 295, 14.11.2017, p. 81).
Provedbena odluka Komisije (EU) 2017/2079 оd 10. studenoga 2017. o odobravanju stavljanja na tržište ekstrakta bogatog taksifolinom kao novog sastojka hrane u skladu s Uredbom (EZ) br. 258/97 Europskog parlamenta i Vijeća (SL L 295, 14.11.2017., str. 81.).
EFSA Journal 2017; 15(11):5059.
EFSA Journal 2017.; 15(11):5059.
The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows:
Prilog Provedbenoj uredbi (EU) 2017/2470 mijenja se kako slijedi:
The entry for ‘Taxifolin-rich extract’ in Table 1 (Authorised novel foods) is replaced by the following:
Unos za „Ekstrakt bogat taksifolinom” u tablici 1. (Odobrena nova hrana) zamjenjuje se sljedećim:
‘Taxifolin-rich extract
„Ekstrakt bogat taksifolinom
The designation of the novel food on the labelling of the foodstuffs containing it shall be “taxifolin-rich extract”’
Pri označivanju hrane koja sadržava novu hranu navodi se ‚Ekstrakt bogat taksifolinomfgi’”
Yogurt plain/Yogurt with fruits (*)
Obični jogurt/voćni jogurt (*)
Kephir (*)
Kefir (*)
Buttermilk (*)
Mlaćenica (*)
Milk powder (*)
Mlijeko u prahu (*)
Cream (*)
Vrhnje (*)
Sour cream (*)
Kiselo vrhnje (*)
Cheese (*)
Sir (*)
Butter (*)
Maslac (*)
Chocolate confectionery
Čokoladne slastice
Food supplements as defined in Directive 2002/46/EC intended for the general population, excluding infants, young children, children and adolescents younger than 14 years
Dodaci prehrani u smislu Direktive 2002/46/EZ namijenjeni općoj populaciji, isključujući dojenčad, malu djecu, djecu i adolescente mlađe od 14 godina
When used in milk products Taxifolin-rich extract may not replace in whole or in part, any milk constituent
Upotrebom ekstrakta bogatog taksifolinom u mliječnim proizvodima ne može se u cijelosti ili djelomično nadomjestiti bilo koji sastojak mlijeka.
The entry for ‘Definition’ for ‘Taxifolin-rich extract’ in in Table 2 (Specifications) is replaced by the following:
Unos za „Definicija” za „Ekstrakt bogat taksifolinom” u tablici 2. (Specifikacije) zamjenjuje se sljedećim:
Chemical name: [(2R,3R)-2-(3,4 dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one, also called (+) trans (2R,3R)- dihydroquercetin] and with no more than 2 % of the cis-form’
Kemijski naziv: [(2R,3R)-2-(3,4 dihidroksifenil)-3,5,7-trihidroksi-2,3-dihidrokromen-4-on, poznat i pod nazivom (+) trans (2R,3R)- dihidrokvercetin] i s najviše 2 % cis oblika”
With this occasion, the applicant also sought a further extension of the use and use conditions for taxifolin-rich extract to a use as a novel food in milk products for the general population and the inclusion in the specifications information of the novel food of a chemical name that was not contained in the original application but was included in the EFSA opinion of 2016.
Tom prilikom podnositelj zahtjeva zatražio je i dodatno proširenje uporabe i uvjeta uporabe ekstrakta bogatog taksifolinom na uporabu kao nova hrana u mliječnim proizvodima namijenjenima općoj populaciji te uključivanje kemijskog naziva u informacije o specifikacijama nove hrane, kojeg nije bilo u izvornom zahtjevu, no koji je naveden u mišljenju EFSA-e iz 2016.
For these extensions of use the applicant provided additional information to EFSA.
Za to proširenje uporabe podnositelj zahtjeva dostavio je EFSA-i dodatne informacije.
Commission Implementing Regulation (EU) 2018/462
Provedbena uredba Komisije (EU) 2018/462
authorising an extension of use of L-ergothioneine as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) 2017/2470
o odobravanju proširenja uporabe L-ergotioneina kao nove hrane u skladu s Uredbom (EU) 2015/2283 Europskog parlamenta i Vijeća i o izmjeni Provedbene uredbe Komisije (EU) 2017/2470
Pursuant to Article 12 of Regulation (EU) 2015/2283, the Commission shall submit a draft implementing act on the placing on the Union market of a novel food and on the updating of the Union list.
U skladu s člankom 12. Uredbe (EU) 2015/2283 Komisija podnosi nacrt provedbenog akta o stavljanju nove hrane na tržište Unije i o ažuriranju popisa Unije.
On 25 July 2013, the company Tetrahedron made a request to the competent authority of France to place synthetic L-ergothioneine (‘L-ergothioneine’) on the Union market as a novel food ingredient within the meaning of point (c) of Article 1(2) of Regulation (EC) No 258/97.
Društvo Tetrahedron podnijelo je 25. srpnja 2013. francuskom nadležnom tijelu zahtjev za stavljanje na tržište Unije L-ergotioneina („L-ergotionein”) kao novog sastojka hrane u smislu članka 1. stavka 2. točke (c) Uredbe (EZ) br. 258/97.
The application requested for L-ergothioneine to be used in food supplements for the general population excluding pregnant and lactating women and for children older than three years, and in non-alcoholic beverages, fresh milk products, milk based drinks, cereal bars and chocolate for the general population excluding pregnant and lactating women, infants and young children.
Zahtjev se odnosio na odobrenje uporabe L-ergotioneina u dodacima prehrani namijenjenima općoj populaciji, osim za trudnice i dojilje, i djeci starijoj od tri godine te u bezalkoholnim pićima, svježim mliječnim proizvodima, napitcima na bazi mlijeka, žitnim pločicama i čokoladi namijenjenima općoj populaciji, osim za trudnice, dojilje, dojenčad i malu djecu.
On 26 October 2016, EFSA adopted a ‘Scientific Opinion on the safety of L-ergothioneine as a novel food pursuant to Regulation (EC) No 258/97’.
EFSA je 26. listopada 2016. donijela „Znanstveno mišljenje o sigurnosti L-ergotioneina kao nove hrane u skladu s Uredbom (EZ) br. 258/97”.
In its opinion it concluded that L-ergothioneine is safe for the proposed uses and use levels.
U svojem je mišljenju zaključila da je L-ergotionein siguran u okviru predloženih uporaba i razina uporabe.
Commission Implementing Decision (EU) 2017/1281 authorised, in accordance with Regulation (EC) No 258/97, the placing on the market of L-ergothioneine as a novel food ingredient to be used in food supplements intended for the general population, excluding infants and young children, pregnant and lactating women.
Provedbenom odlukom Komisije (EU) 2017/1281 odobreno je, u skladu s Uredbom (EZ) br. 258/97, stavljanje na tržište L-ergotioneina kao novog sastojka hrane koji se upotrebljava u dodacima prehrani namijenjenima općoj populaciji, osim za dojenčad, malu djecu, trudnice i dojilje.
The Commission initiated a further evaluation before taking a final decision on the full scope of the application, in order to ensure that L-ergothioneine is also safe when consumed in other forms than in food supplements by infants, young children, pregnant and lactating women.
Komisija je prije donošenja konačne odluke o sveobuhvatnom području uporabe pokrenula dodatnu procjenu kako bi utvrdila je li za dojenčad, malu djecu, trudnice i dojilje konzumiranje L-ergotioneina, osim u dodacima prehrani, sigurno i u drugim oblicima.
On 26 April 2017, the applicant was informed of and agreed with the Commission's additional request to EFSA.
Podnositelj je 26. travnja 2017. obaviješten o dodatnom zahtjevu koji je Komisija uputila EFSA-i i s njime se složio.
On 19 May 2017, the Commission consulted EFSA asking it to carry out a supplementary safety assessment for L-ergothioneine in non-alcoholic beverages, fresh milk products, milk-based drinks, cereal bars and chocolate for pregnant and lactating women, infants and young children.
Komisija je 19. svibnja 2017. zatražila od EFSA-e da provede dodatnu procjenu sigurnosti za L-ergotionein u bezalkoholnim pićima, svježim mliječnim proizvodima, napitcima na bazi mlijeka, žitnim pločicama i čokoladi namijenjenima trudnicama i dojiljama te dojenčadi i maloj djeci.
Pursuant to Article 35(1) of Regulation (EU) 2015/2283, any request for placing a novel food on the market within the Union submitted to a Member State in accordance with Article 4 of Regulation (EC) No 258/97 concerning novel foods and novel food ingredients and for which the final decision has not been taken before 1 January 2018 shall be treated as an application submitted under Regulation (EU) 2015/2283.
U skladu s člankom 35. stavkom 1. Uredbe (EU) 2015/2283 svi zahtjevi za stavljanje nove hrane na tržište u Uniji koji su podneseni državi članici u skladu s člankom 4. Uredbe (EZ) br. 258/97 o novoj hrani i sastojcima nove hrane i za koje nije donesena konačna odluka prije 1. siječnja 2018. tretiraju se kao zahtjevi u skladu s Uredbom (EU) 2015/2283.
On 25 October 2017, EFSA adopted a ‘Scientific Opinion on the safety of L-ergothioneine’.
EFSA je 25. listopada 2017. donijela „Znanstveno mišljenje o sigurnosti L-ergotioneina”.
This opinion, although elaborated and adopted by EFSA under Regulation (EC) No 258/97 is in line with the requirements of Article 11 of Regulation (EU) 2015/2283.
Iako je EFSA to mišljenje izradila i donijela na temelju Uredbe (EZ) br. 258/97, ono je u skladu sa zahtjevima iz članka 11. Uredbe (EU) 2015/2283.
The opinion gives sufficient grounds to establish that L-ergothioneine when used as an ingredient in non-alcoholic beverages, fresh milk products, milk-based drinks, cereal bars and chocolate confectionery taking into account all population groups, complies with Article 12(1) of Regulation (EU) 2015/2283.
U mišljenju se iznosi dovoljno informacija na temelju kojih se može utvrditi da je, uzimajući u obzir sve skupine stanovništva, uporaba L-ergotioneina kao sastojka u bezalkoholnim pićima, svježim mliječnim proizvodima, napitcima na bazi mlijeka, žitnim pločicama i čokoladnim slasticama u skladu s člankom 12. stavkom 1. Uredbe (EU) 2015/2283.
Regulation (EU) No 1308/2013 of the European Parliament and of the Council establishing a common organisation of the markets in agricultural products lays down requirements for milk and milk products which apply to L-ergothioneine when used as an ingredient in milk products.
Uredbom (EU) br. 1308/2013 Europskog parlamenta i Vijeća o uspostavljanju zajedničke organizacije tržišta poljoprivrednih proizvoda utvrđeni su zahtjevi za mlijeko i mliječne proizvode koji se primjenjuju na L-ergotionein ako se upotrebljava kao sastojak u mliječnim proizvodima.
Pursuant to its point 2 of Part III of Annex VII L-ergothioneine cannot be used in milk products to replace, in whole or in part, any milk constituent.
U skladu s dijelom III. točkom 2. Priloga VII. L-ergotionein ne može se upotrebljavati u mliječnim proizvodima kako bi se u cijelosti ili djelomično nadomjestio bilo koji sastojak mlijeka.